Cited by 456Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Alzheimer's disease

Mucke, Lennart·2009·Nature

Integrity signals

Registry

Crossref · 10.1038/461895a

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Efforts to rationally design AD therapeutics based on compounds that control Aβ aggregation have been hampered by the lack of a complete understanding of the neurotoxic role of various Aβ aggregates.

    “In this regard, efforts to rationally design AD therapeutics based on compounds that control Aβ aggregation have been hampered by the lack of a complete understanding of the neurotoxic role of various Aβ aggregates.22”

Cited by

Sorted by citations

Authors
Mucke, L.
Affiliations
University of California, San Francisco (US)
Corresponding author
Mucke, Lennart
Venue
Nature
Published
2009-10
Volume
461
Issue
7266
Pages
895-897
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2066918975
Cited by
456
References
0
Citations by year
2026: 12 · 2025: 30 · 2024: 34 · 2023: 43 · 2022: 62 · 2021: 44 · 2020: 20 · 2019: 21 · 2018: 19 · 2017: 19 · 2016: 27 · 2015: 22 · 2014: 14 · 2013: 22 · 2012: 27
FWCI
14.08
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, neurodegeneration, population aging, drug development, drug evaluation, disease mechanisms
MeSH terms
Aging, Alzheimer Disease, Animals, Genetic Testing, Humans, United States, Amyloid beta-Peptides, Treatment Failure, Age of Onset, Controlled Clinical Trials as Topic, Stem Cell Transplantation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review